Pharmaceuticals in Netherlands

May 2020 | 47 pages | ID: PF5A6557FDCEN
MarketLine

Abstracts

Pharmaceuticals in Netherlands

SUMMARY

Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
• The Dutch pharmaceuticals market had total revenues of $4,714.2m in 2019, representing a compound annual rate of change (CARC) of -3.6% between 2015 and 2019.
• Healthcare in the Netherlands is covered by basic health insurance, which everyone that lives or works in the Netherlands is legally required to have. The contents of this insurance are the same for everyone, financed by fixed health insurance premiums of the adult population.
• In conjunction with the Belgian government, the Dutch government is actively stopping companies from raising pharmaceutical prices, which is slowing generics market growth as well as in the wider pharmaceutical market.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in the Netherlands
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the Netherlands
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands pharmaceuticals market with five year forecasts

REASONS TO BUY

• What was the size of the Netherlands pharmaceuticals market by value in 2019?
• What will be the size of the Netherlands pharmaceuticals market in 2024?
• What factors are affecting the strength of competition in the Netherlands pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitiors in the Netherlands's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. Are there any threats towards leading players?

8 COMPANY PROFILES

8.1. Novartis AG
8.2. Pfizer Inc.
8.3. AstraZeneca AB
8.4. GlaxoSmithKline Plc

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Netherlands pharmaceuticals market value: $ billion, 2015-19
Table 2: Netherlands pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Netherlands pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Netherlands pharmaceuticals market share: % share, by value, 2019
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Annual Financial Ratios (Continued)
Table 8: Novartis AG: Key Employees
Table 9: Novartis AG: Key Employees Continued
Table 10: Pfizer Inc.: key facts
Table 11: Pfizer Inc.: Annual Financial Ratios
Table 12: Pfizer Inc.: Key Employees
Table 13: Pfizer Inc.: Key Employees Continued
Table 14: AstraZeneca AB: key facts
Table 15: AstraZeneca AB: Key Employees
Table 16: GlaxoSmithKline Plc: key facts
Table 17: GlaxoSmithKline Plc: Annual Financial Ratios
Table 18: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 19: GlaxoSmithKline Plc: Key Employees
Table 20: GlaxoSmithKline Plc: Key Employees Continued
Table 21: Netherlands size of population (million), 2015-19
Table 22: Netherlands gdp (constant 2005 prices, $ billion), 2015-19
Table 23: Netherlands gdp (current prices, $ billion), 2015-19
Table 24: Netherlands inflation, 2015-19
Table 25: Netherlands consumer price index (absolute), 2015-19
Table 26: Netherlands exchange rate, 2015-19

List Of Figures

LIST OF FIGURES

Figure 1: Netherlands pharmaceuticals market value: $ billion, 2015-19
Figure 2: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Netherlands pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in the Netherlands, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2019
Figure 10: Netherlands pharmaceuticals market share: % share, by value, 2019